Acumen Pharmaceuticals (ABOS) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T12:05:16.666Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:05:16.666Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -105,095,000
Quote market capitalization: 153,844,788
Total debt · period ending 2026-06-30: 31,569,000
Cash · period ending 2026-06-30: 59,443,000

FMP input reference: 5d81df243028a463df18dadfb6b81954a95dec5b5738e9798e17a16434fd93e0

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

ABOS EBITDA Yield Metrics

EBITDA YIELD

N/A

ABOS Competitors' EBITDA Yield

ABOS

Acumen Pharmaceuticals, Inc.

Current

Market Cap

$153.84M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVXL

Anavex Life Sciences Corp.

vs ABOS

Market Cap

$152.45M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRDL

Cardiol Therapeutics Inc.

vs ABOS

Market Cap

$152.16M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDXS

Codexis, Inc.

vs ABOS

Market Cap

$149.51M

EBITDA Yield

N/A

TTM Avg

1.29%

3Y Avg

1.28%

5Y Avg

1.28%

ALXO

ALX Oncology Holdings Inc.

vs ABOS

Market Cap

$162.82M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBIOP

Fortress Biotech, Inc.

vs ABOS

Market Cap

$142.49M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACOG

Alpha Cognition Inc

vs ABOS

Market Cap

$142.11M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FRNM

Freenome, Inc.

vs ABOS

Market Cap

$137.29M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIRS

AirSculpt Technologies, Inc.

vs ABOS

Market Cap

$134.74M

EBITDA Yield

0.23%

TTM Avg

0.33%

3Y Avg

3.24%

5Y Avg

2.95%

CMPX

Compass Therapeutics, Inc.

vs ABOS

Market Cap

$172.99M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Acumen Pharmaceuticals, Inc. (ABOS)	$153.84M	N/A	N/A	N/A	N/A
Anavex Life Sciences Corp. (AVXL)vs ›	$152.45M	N/A	N/A	N/A	N/A
Cardiol Therapeutics Inc. (CRDL)vs ›	$152.16M	N/A	N/A	N/A	N/A
Codexis, Inc. (CDXS)vs ›	$149.51M	N/A	1.29%	1.28%	1.28%
ALX Oncology Holdings Inc. (ALXO)vs ›	$162.82M	N/A	N/A	N/A	N/A
Fortress Biotech, Inc. (FBIOP)vs ›	$142.49M	N/A	N/A	N/A	N/A
Alpha Cognition Inc (ACOG)vs ›	$142.11M	N/A	N/A	N/A	N/A
Freenome, Inc. (FRNM)vs ›	$137.29M	N/A	N/A	N/A	N/A
AirSculpt Technologies, Inc. (AIRS)vs ›	$134.74M	0.23%	0.33%	3.24%	2.95%
Compass Therapeutics, Inc. (CMPX)vs ›	$172.99M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

ABOS EBITDA Yield Metrics

ABOS Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics